OCM-1A uveal melanoma cells were infected with lentivirus carrying shRNA expression constructs specific for BAP1 or GFP (control), and placed under selection for 6 days. RNA-seq was performed. Overall design: Samples represent three independent experiments treated with control or BAP1 shRNA
Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma.
Specimen part, Cell line, Treatment, Subject, Time
View Samples